Pioneering research to fight
pulmonary fibrosis and lung infection

Donate

Post-COVID lung microbes stay healthy

New research shows the lung microbiome in patients with post-COVID residual lung changes is similar to healthy lungs and distinct from pulmonary fibrosis, offering insights into recovery and long-term lung health.

Many people who had COVID-19 are left with residual lung changes – areas of the lung that look abnormal on scans – even months after infection. Experts have wondered whether these changes might lead to long-term lung damage, similar to conditions like idiopathic pulmonary fibrosis (IPF).

A new study from the UK Interstitial Lung Disease (UKILD) consortium and the POSTCODE team investigated whether the lung microbiome (bacteria living in our airways) might play a role in these post-COVID lung changes. Breathing Matters-funded researchers contributed to this study.

Using advanced testing on lung fluid samples from patients about a year after COVID-19 infection, researchers compared their lung bacteria with people who have IPF, fibrotic hypersensitivity pneumonitis (fHP), and healthy volunteers.

Key Findings:

  • Healthy microbiome: People with post-COVID lung changes had a lung microbiome similar to healthy individuals.
  • Different from fibrotic disease: Their lung bacteria were clearly different from those in IPF, which is associated with harmful changes in the microbiome.
  • No link to severity: The types or amounts of bacteria did not seem to influence the severity of lung changes or how well patients recovered.
  • Dominant bacteria: Some bacteria like Streptococcus were slightly more abundant, but this did not affect recovery.

What This Means for Patients:

  • Good news: Post-COVID lung changes do not appear to be caused by harmful bacterial shifts in the lungs.
  • No major long-term infection risk: The microbiome is not likely contributing to lung damage after COVID-19.
  • Hope for recovery: This supports the idea that most post-COVID lung changes may gradually improve over time without the complications seen in serious fibrotic diseases, seen in IPF.

Next Steps in Research:

Researchers recommend continued monitoring and long-term imaging studies to track lung recovery, but this study suggests that bacterial imbalance is not a driver of post-COVID lung problems.

Conclusion:

If you are living with lingering lung changes after COVID-19, this research is reassuring – your lung bacteria are likely healthy, and your recovery may follow a natural course. Ongoing research will continue to explore the best ways to support lung health after COVID-19.

Full article: ERJ Open Research 2025 11(3): 00826-2024

[Posted February 2026]

Sign up to receive our news and updates

  • This form collects your name and email address so that we can keep you updated with news and information about Breathing Matters. Please check our Privacy Policy to see how we protect and manage your data.

Where there's research there's hope

Research into respiratory conditions accounts for just 2% of all the medical research funding in the UK.

Will you support our research?